Retinoschisis
10
1
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis
The AXIS Study: the Efficacy of Acetazolamide for the Treatment of Cystoid Fluid Collections in Retinoschisis
Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis
Inherited Retinal Degenerative Disease Registry
Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial
Mothers Experiences With X-linked Retinoschisis Compared to Fathers Experiences
Effects of Macular Buckle Versus Vitrectomy on Macular Schisis and Macular Detachment in Highly Myopic Eyes
Postoperative Pain Control Following Vitreoretinal Surgery
Optical Coherence Tomography Evaluation of Retinoschisis and Retinal Detachment